Skip to main content
Premium Trial:

Request an Annual Quote

French Informatics Company IT.OMICS Licenses Data Miner to Galderna

NEW YORK, Oct. 19 (GenomeWeb News) - Bioinformatics company IT.OMICS has given French-Swiss drug maker Galderma access to its LSGraph data-mining technology.


LSGraph enables researchers to mine the functional relationships between all known genes, proteins, and chemical compounds in the scientific literature.


Galderma is the fifth drug maker to license the technology in the past six months. The other four were Aventis, UCB Pharma, Proskelia, and Genfit.


Financial terms of the agreement were not disclosed.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.